The “Global Pharma Study 2023” by Caliber provides comprehensive insights into the reputation of the global pharmaceutical industry.
The study also highlights a significant gap in perceptions between customers and the general public, suggesting the need for the industry to better communicate its societal contributions.
Haleon emerged as the top-rated pharma company in 2022, while companies involved in COVID-19 vaccine production saw their reputations decline as the pandemic’s urgency waned.
The study is based on interviews with over 17,600 people across seven countries.
Uncover key insights into the evolving reputation of the pharmaceutical industry
Here's what you'll discover:
How has the reputation of the pharmaceutical industry evolved from 2022 to 2023, particularly in the context of the post-COVID-19 era?
What are the main factors contributing to the differences in public perceptions of pharmaceutical companies across various markets?
Which demographic groups hold the most positive and negative views of the pharmaceutical industry, and why?
How do the strengths in innovation and leadership contrast with the industry's challenges in integrity and brand perception?
What issues do healthcare professionals and the general public believe the pharmaceutical industry needs to address to build trust and improve its reputation?
Sign up for a non-binding demo today and find out how your brand is doing!
